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Takahashi et al. demonstrated a novel cellular axis involving intestinal
epithelial cells (IECs) and adipocytes. Several properties of this axis
were important. Firstly, they observed an increase in MMP-9 mRNA in
IECs when co-cultured with adipocytes that had differentiated from
murine embryonic fibroblasts. Importantly, no increase in MMP-9Keywords:
Intestine
Epithelium
Adipocyte
MesenteryCrohn's disease is hallmarked by mesenteric abnormalities including
thickening, shortening and extension ofmesenteric fat over the intestinal
surface (“fat wrapping” or “creeping fat”) (Coffey et al., 2016; Peyrin-
Biroulet et al., 2007; Sheehan et al., 1992; Crohn et al., 1932). Mesenteric
and submucosal mesenchymal abnormalities overlap in histological ap-
pearance and both inflammatory fronts meet to generate transmural in-
flammation (Coffey and O'leary, 2016). Multiple cellular abnormalities
underpin these histological changes, including increased collagen deposi-
tion (Li and Kuemmerle, 2014), fibroblast activation (Li and Kuemmerle,
2014), adipocyte hyperplasia (but not hypertrophy) and epithelial to
mesenchymal transformation (Coffey et al., 2016; Peyrin-Biroulet et al.,
2007). Cellular abnormalities occur in the connective tissue that (1) inte-
gratesmesentery and contiguous intestine and (2) is the adult remnant of
mesenteric contributions to outer layers of the intestinal wall during or-
ganogenesis (Coffey et al., 2016; Coffey and O'Leary, 2016).
In Crohn's disease, mesenteric, mural and mucosal disease manifes-
tations are topographically coupled as they increase in tandem (Coffey
et al., 2016; Peyrin-Biroulet et al., 2007; Sheehan et al., 1992). Mucosal
ulceration first develops at the mesenteric margin of the intestinal cir-
cumference (i.e. “axial polarity”) (Crohn et al., 1932; Thompson,
1990). Here, where mesentery intersects intestine, mesenteric inputs
are at their most concentrated. Takahashi et al. confirmed this coupling
by immunostaining for perilipin (which identifies adipocyte droplets).
Intestinal epithelial damage was marked where the intestine and mes-
entery were contiguous (Takahashi et al., 2017).m.2017.07.027.
, Limerick, Ireland.
.V. This is an open access article undIn investigating the cellular and molecular basis of this coupling,
mRNA expression was observed when IECs when these were co-cul-
tured with murine embryonic fibroblasts. This differential responsivity
is highly relevant and is further discussed below.
Takahashi et al. also observed a reduction in Villin-1 and glycopro-
tein 33 mRNA expression (both proteins exert anti-inflammatory ef-
fects) in IECs co-cultured with adipocytes. This profile of gene
expression changes induced by co-culture with fibroblast-derived adi-
pocytes point to the activity of an inter-cellular signalling pathway
that could explain coupling of mesenteric, mucosal and mural manifes-
tations seen in Crohn's disease.
The differential effect of adipcoyte and fibroblast co-culture with
IECs is particularly important. Crohn's disease has multiple phenotypes
characterised by different macroscopic features (inflammatory,
stricturing and fistulating) (Gasche et al., 2000). The cellular andmolec-
ular basis of these differences are notwell defined, but definitionmay be
informed by the observations of Takahashi et al. In this context it is im-
portant to recall that the adipocytes generated by Takahashi et al. were
firstly derived from murine embryonic fibroblasts. In addition, adipo-
cyte (but not fibroblast) co-culture, led to an increase in epithelial
MMP-9 mRNA expression.
Taking the above and other observations into account, an intuitive
cellular hypothesis arises based on differential fibroblast differentiation,
adipocyte generation and adipocyte/epithelial interactions. According
to this hypothesis three scenarios are possible. In the first, adipocyte dif-
ferentiation dominates. As a result, IEC/adipocyte cellular activity is sub-
stantial and triggers an overall inflammatory phenotype (increased
MMP-9, IL-6 and TNFwith reduced Villin-1 and glycoprotein 33 expres-
sion). In the second scenario, adipocyte differentiation is non-dominant.
The adipocyte/epithelial axis is relatively less active and fibroblastic
mesenchymal activities lead to an overall stricturing phenotype. In the
third scenario, differentiation is balanced. As a result inflammation
(driven by epithelial/adipocyte interactions) and fibrosis occur in tan-
dem and lead to a fistulating phenotype. Hence, varying rates of fibro-
blast differentiation, coupled with differential potency of adipocyte/
epithelial inputs could explain many of the phenotypic variations of
Crohn's disease.er the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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lent indicator of the success or failure of medical management. Overall,
surgery rates appear largely unaltered in Crohn's disease, despite the
global usage of monoclonal antibodies targeting either cytokines,
integrins and other molecular mediators (Burke et al., 2013). This
observation is partially explained by the findings of Takahashi et al.
who showed that whilst a TNF neutralising antibody reduced
mRNA levels in intestinal epithelial cells, adipocytes were unaffect-
ed. Given the relative importance of adipose mesenchyme in the
mesentery and submucosa in Crohn's disease, alternate
pharmacotherapeutic approaches may be required to reduce the re-
quirement for surgical intervention. It is feasible that Takahashi et al.
have identified one such approach, i.e. disrupting signalling between
adipocytes and intestinal epithelia. They showed that MMP-9 mRNA
production was increased in intestinal epithelium when cultured in
adipocyte conditioned medium. The reverse did not hold in that
MMP-9 mRNA expression did not increase in adipocytes cultured in
epithelial conditioned medium. They also showed that targeting of
NF-κB and STAT-3 disrupted the epithelial response to culture in ad-
ipocyte-conditioned medium. Hence, adipocyte-related induction of
pro-inflammatory responses in intestinal epithelia may be
pharmaco-therapeutically disrupted.
Emerging data indicate that inclusion of the mesentery during re-
section for ileocolic Crohn's disease, may lead to reduced rates of sur-
gical recurrence (i.e. recurrence requiring surgical intervention)1.
That being said, surgical intervention remains a radical intervention
with risk, and the development of pharmaco-therapeutic means of
targeting the adipose fraction of mesentery should be developed.
The findings of the present study support future in vivo studies ex-
amining interactions between intestinal epithelial and mesenteric-
derived mesenchymal cell populations (i.e. adipocyte and fibroblast
fractions). They also support the development of non-invasive
means of diagnosing and therapeutically altering mesenteric mani-
festations of Crohn's disease.Conflict of interests
The authors declare no conflicts of interest.References
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